AADALBIOTECH ApS: Financial statements 2023
CVR: 31759668
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
AADALBIOTECH ApS (CVR 31759668) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 84,899 and a net result of DKK 77,039 compared with DKK -51,607 the year before. The profit margin was 90.7%. Equity in the 2023 report amounted to DKK 43,598. The solvency ratio was 43%.
- Revenue
- DKK 84,899
- Gross Profit
- DKK 73,907
- Profit/Loss
- DKK 77,039
- Equity
- DKK 43,598
- Total Assets
- DKK 101,282
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 85 t. | 74 t. | 77 t. | 44 t. | - |
| 2022 | 0 | - | -52 t. | -33 t. | 1 |
| 2021 | 20 t. | - | 76 t. | 18 t. | 1 |
| 2020 | 17 t. | - | -30 t. | -58 t. | 1 |
| 2019 | - | - | -14 t. | -28 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
AADALBIOTECH ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -51,607.
About AADALBIOTECH ApS
AADALBIOTECH ApS is a Danish company of the type Anpartsselskab based in Ringsted, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Peter Aadal Nielsen. The company is owned by Peter Aadal Nielsen and Søren Aadal Nielsen. The company has 1 employee (2011). In 2025, the company reported a gross profit of DKK 637,391 and a net result of DKK 496,669 compared with DKK 35,393 the year before. Equity in the 2025 report amounted to DKK 575,660.